The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial
Open accessAbstract
Butyrate analogues have been shown to increase fetal hemoglobin (HbF) production in vitro and in vivo. Sodium phenylbutyrate (SPB), an oral agent used to treat individuals with urea-cycle disorders, has been shown to increase HbF in nonanemic individuals and in individuals with sickle cell disease. We have treated eleven patients with homozygous beta thalassemia (three transfusion dependent) and one sickle-beta- thalassemia patient with 20 g/d (forty 500-mg tablets) of SPB for 41 to 460 days. All patients showed an increase in the percent of F reticulocytes associated with treatment, but only four patients responded by increasing their Hb levels by greater than 1 g/dL (mean increase, 2.1 g/dL; range, 1.2 to 2.8 g/dL). None of the transfusion- dependent thalassemia subjects responded. Increase in Hb was associated with an increase in red blood cell number (mean increase, 0.62 x 10(12)/L), and mean corpuscular volume (mean increase, 6 fL). Changes in percent HbF, absolute HbF levels, or alpha- to non-alpha-globin ratios as measured by levels of mRNA and globin protein in peripheral blood did not correlate with response to treatment. Response to treatment was not associated with the type of beta-globin mutation, but baseline erythropoietin levels of greater than 120 mU/mL was seen in all responders and only two of eight nonresponders to SPB. Compliance with treatment was greater than 90% as measured by pill counts. Side effects of the drug included weight gain and/or edema caused by increase salt load in 2/12, transient epigastric discomfort in 7/12, and abnormal body odor in 3/12 subjects. Two splenectomized patients who were not on prophylactic antibiotics developed sepsis while on treatment. We conclude that SPB increases Hb in some patients with thalassemia, but the precise mechanism of action is unknown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR
Zurlo, M., De Stefano, P., Borgna-Pignatti, C., Di Palma, A., Melevendi, C., Piga, A., Di Gregorio, F., Burattini, M., & Terzoli, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90264-x · Cited by 611
5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia
Ley, T. J., DeSimone, J., Anagnou, N. P., Keller, G. H., Humphries, R. K., Turner, P. H., Young, N. S., Heller, P., & Nienhuis, A. W. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212093072401 · Cited by 490
Induction of erythroid differentiation in the human leukaemia cell line K562
ANDERSSON, L. C., JOKINEN, M., & GAHMBERG, C. G. (1979) · Nature · doi:10.1038/278364a0 · Cited by 466
A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders
Perrine, S. P., Ginder, G. D., Faller, D. V., Dover, G. H., Ikuta, T., Witkowska, H. E., Cai, S.-P., Vichinsky, E. P., & Olivieri, N. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280202 · Cited by 437
Self-citationDover, G., Brusilow, S., & Charache, S. (1994) · Blood · doi:10.1182/blood.v84.1.339.339 · Cited by 232
Self-citationMarrow Transplantation in Patients with Thalassemia Responsive to Iron Chelation Therapy
Lucarelli, G., Galimberti, M., Polchi, P., Angelucci, E., Baronciani, D., Giardini, C., Andreani, M., Agostinelli, F., Albertini, F., & Clift, R. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309163291204 · Cited by 227
Dover, G., Smith, K., Chang, Y., Purvis, S., Mays, A., Meyers, D., Sheils, C., & Serjeant, G. (1992) · Blood · doi:10.1182/blood.v80.3.816.816 · Cited by 196
Self-citationDelay in the Fetal Globin Switch in Infants of Diabetic Mothers
Perrine, S. P., Greene, M. F., & Faller, D. V. (1985) · New England Journal of Medicine · doi:10.1056/nejm198502073120602 · Cited by 172
Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion
Brusilow, S. W. (1991) · Pediatric Research · doi:10.1203/00006450-199102000-00009 · Cited by 169
Self-citationPhenylacetate: a novel nontoxic inducer of tumor cell differentiation.
Samid, D., Shack, S., & Sherman, L. T. (1992) · PubMed · Cited by 144
Cited by
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Melnick, A., & Licht, J. D. (1999) · Blood · doi:10.1182/blood.v93.10.3167.410k44_3167_3215 · Cited by 1,028
Olivieri, N. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410207 · Cited by 728
Ferrante, R. J., Kubilus, J. K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi-Carter, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 693
Metadata
- Authors
- Collins, A., Pearson, H., Giardina, P., McDonagh, K., Brusilow, S., & Dover, G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1995-01-01
- Volume
- 85
- Issue
- 1
- Pages
- 43-49
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1488281450
- Cited by
- 261
- References
- 29
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. https://app.cochat.ai/papers/10.1182/blood.v85.1.43.bloodjournal85143
- The paper
- Collins, A., Pearson, H., Giardina, P., McDonagh, K., Brusilow, S., & Dover, G. (1995). Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. Blood. https://doi.org/10.1182/blood.v85.1.43.bloodjournal85143
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.